Fujifilm may restart clinical trial of Avigan for COVID-19 - Health - The Jakarta Post
New research shows how Indonesia's drug control victimizes women and puts their health at risk
BUMN Covid-19 Vaccine Kicks Off Phase 3 Clinical Trial - Jakarta Globe
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study - The Lancet Haematology
PDF) Critical appraisal on journal of clinical trials
Indonesia begins clinical trials of homegrown COVID-19 candidate vaccine - Society - The Jakarta Post
GlomCon - Join us tomorrow for our Clinical Trial Series with @nephcure by Dr. Laura Barisoni on Pathology and Clinical Trials Join https://glomcon.zoom.us Mtng ID: 937 9592 6539 Passcode 202122 sign up
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis | Leukemia
GlomCon on Twitter: "Together with @Nephcure & endorsed by #KidneyHealthInitiative & @ASNKidney we present Episode 3: FSGS What is our current understanding? Where is the latest research taking us? What opportunities do
The Current Status of Clinical Trials in Indonesia
A randomized controlled clinical trial of carbohydrate mix-fortified nutrition in type 2 diabetes mellitus patients | Medical Journal of Indonesia
Multi-Discipline Review
Typhoid conjugate vaccine from Indonesia found to be safe, immunogenic in phase 1 clinical trial - IVI
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis | Leukemia
Phase 3 Fabry Trial Shows PRX-102 Has More Stability Over Other ERTs
Clinical utility of fedratinib in myelofibrosis | OTT
When clinical trials turn deadly. | MPNforum Magazine
Ongoing clinical trials with JAK2 inhibitors in MF - ppt download
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study - The Lancet Haematology
A Look at Fedratinib and the JAKARTA Trials
HEALTHCARE RESOURCE UTILIZATION (HRU) IN THE RANDOMIZED,.... EHA Library. Mesa R. Jun 12 2020; 294220
Ruxolitinib Continues to Show Strong Efficacy as Frontline Therapy in Myelofibrosis
Pediatric GN Trials - YouTube
A Look at Fedratinib and the JAKARTA Trials
